Shares of Sareum Holdings plc (LON:SAR – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 26.03 ($0.32) and traded as low as GBX 14.83 ($0.18). Sareum shares last traded at GBX 16 ($0.20), with a volume of 2,324,149 shares.
Sareum Trading Up 0.8 %
The firm’s fifty day moving average price is GBX 26.03 and its 200 day moving average price is GBX 49.10. The stock has a market capitalization of £11.57 million, a price-to-earnings ratio of -320.00 and a beta of -0.69.
Sareum Company Profile
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
See Also
- Five stocks we like better than Sareum
- Using the MarketBeat Dividend Tax Calculator
- The Charles Schwab Company Can Hit New Highs
- Energy and Oil Stocks Explained
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
